Robert L Nussbaum
Overview
Explore the profile of Robert L Nussbaum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
171
Citations
11121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hatchell K, Poll S, Russell E, Williams T, Ellsworth R, Facio F, et al.
Am J Hum Genet
. 2025 Jan;
112(3):481-491.
PMID: 39884281
Various scientific and professional groups, including the American Medical Association (AMA), American Society of Human Genetics (ASHG), American College of Medical Genetics (ACMG), and the National Academies of Sciences, Engineering,...
2.
Manirakiza A, Baichoo S, Uwineza A, Dukundane D, Uwinkindi F, Ngendahayo E, et al.
NPJ Genom Med
. 2024 Nov;
9(1):61.
PMID: 39582020
Cancer genetic data from Sub-Saharan African (SSA) are limited. Patients with female breast (fBC), male breast (mBC), and prostate cancer (PC) in Rwanda underwent germline genetic testing and counseling. Demographic...
3.
Shore N, Pieczonka C, Heron S, Gazi M, Cahn D, Belkoff L, et al.
J Urol
. 2024 Sep;
212(6):842-843.
PMID: 39226588
No abstract available.
4.
Shore N, Pieczonka C, Heron S, Gazi M, Cahn D, Belkoff L, et al.
J Urol
. 2024 Aug;
212(6):832-843.
PMID: 39121056
Purpose: Identification of pathogenic germline variants in patients with prostate cancer can help inform treatment selection, screening for secondary malignancies, and cascade testing. Limited real-world data are available on clinician...
5.
Abdel-Razeq H, Sharaf B, Bani Hani H, Abu Hijlih R, Alkyam M, Al-Azzam K, et al.
JCO Glob Oncol
. 2024 Jun;
10:e2400068.
PMID: 38843472
Purpose: Germline genetic testing (GGT) significantly affects cancer care. While universal testing has been studied in Western societies, less is known about adoption elsewhere. Materials And Methods: In this study,...
6.
Morales A, Moretz C, Ren S, Smith E, Callis T, Hall T, et al.
Circ Genom Precis Med
. 2023 Dec;
17(1):e004028.
PMID: 38088168
No abstract available.
7.
Sorscher S, Lopiccolo J, Heald B, Chen E, Bristow S, Michalski S, et al.
JCO Precis Oncol
. 2023 Nov;
7:e2300190.
PMID: 37992258
Purpose: Germline genetic testing (GGT) is now recommended for all patients diagnosed with ovarian or pancreatic cancer and for a large proportion of patients based solely on a diagnosis of...
8.
Heald B, Pirzadeh-Miller S, Ellsworth R, Nielsen S, Russell E, Beitsch P, et al.
J Natl Cancer Inst
. 2023 Sep;
116(2):334-337.
PMID: 37756683
Current guidelines recommend single variant testing in relatives of patients with known pathogenic or likely pathogenic germline variants in cancer predisposition genes. This approach may preclude the use of risk-reducing...
9.
Shore N, Gazi M, Pieczonka C, Heron S, Modh R, Cahn D, et al.
Eur Urol Oncol
. 2023 Aug;
6(5):477-483.
PMID: 37574391
Background: Prostate cancer (PCa) patients with pathogenic/likely pathogenic germline variants (PGVs) in cancer predisposition genes may be eligible for U.S. Food and Drug Administration-approved targeted therapies, clinical trials, or enhanced...
10.
Aradhya S, Facio F, Metz H, Manders T, Colavin A, Kobayashi Y, et al.
Am J Med Genet C Semin Med Genet
. 2023 Jul;
193(3):e32057.
PMID: 37507620
The transition from analog to digital technologies in clinical laboratory genomics is ushering in an era of "big data" in ways that will exceed human capacity to rapidly and reproducibly...